GlassScriptPhysician profile
Peter Edward Dowling
NPI 1952373144
$524.86
in general payments reported to CMS, 2019-2025
10 companies · $74.60 in 2025
The $74.60 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $135 · 2021: $142 · 2023: $126 · 2024: $47.13 · 2025: $74.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $247.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $142.15 | 2021 | |
| Glaxosmithkline, LLC. | $123.78 | 2019-2023 | Arexvy |
| Abbvie INC. | $117.32 | 2019-2025 | |
| Emd Serono, INC. | $40.10 | 2023-2024 | Mavenclad |
| Bayer Healthcare Pharmaceuticals INC. | $19.17 | 2025 | |
| Organon LLC | $18.63 | 2025 | Nexplanon |
| Mallinckrodt Hospital Products INC. | $18.11 | 2023 | Acthar |
| Sumitomo Pharma America, INC. | $17.65 | 2023 | Myfembree |
| Merck Sharp & Dohme LLC | $15.47 | 2025 | Gardasil 9 |
| Ethicon US, LLC | $12.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Dowling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.